$3million grant for Diabetes Research to an Indian American doctor, Nikhil Dhurandhar

Published On 2015-07-29 08:02 GMT   |   Update On 2015-07-29 08:02 GMT
Advertisement
 Nikhil Dhurandhar, who is president of the Obesity Society has based his research on adenovirus 36, which causes obesity but also releases a protein that reduces the blood sugar level

An Indian-American doctor, Dr Nikhil Dhurandhar has been awarded a $3 million grant to continue his research for treatment of diabetes. Dhurandhar research is a paradoxical situation in itself; it is based on an adenovirus 36 which causes obesity in humans, yet release a protein that reduces the glucose level in the blood.
Advertisement

Dhurandhar first made this interesting observation years ago in rodents while researching how the virus causes obesity. A protein was isolated from the virus that is responsible for reducing blood sugar, and eventually tested on diabetic cells and animals. The result was conclusive, with the protein leading to a marked improvement in diabetes.

The next step was to focus to develop a drug that could be tested on humans and Dhurandhar currently holds a number of patents for his work on adenovirus 36.

Dhurandhar, who is president of the Obesity Society, has been studying viral obesity for years, which he started when he was a physician in India focusing on patients with obesity.
Tags:    

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News